SCHEMBL145676

SCHEMBL145676

Cc1c(Br)ccc(O)c1CNc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 3/20 0.43
ALOX12 P18054 3/20 0.43
CYP1A2 P05177 3/20 0.43
ALDH1A1 P00352 2/20 0.43
PHLPP2 Q6ZVD8 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 5/20 0.41
HPGD P15428 1/20 0.39
HTT P42858 2/20 0.39
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 1/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
ALOX15 P16050 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAOB P27338 1/20 0.37
MEN1 O00255 2/20 0.37
CYP3A4 P08684 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7112667 0.75 HIF1A (0.50) HIF1AALOX12CYP1A2ALDH1A1PHLPP2
SCHEMBL10055003 0.74 HTT (0.52) HIF1ACYP1A2ALDH1A1MAPTHTT
SCHEMBL22279019 0.74 HTT (0.52) HIF1ACYP1A2ALDH1A1MAPTHTT
SCHEMBL14857796 0.71 MAPT (0.45) HIF1ACYP1A2MAPTHPGDHTT
SCHEMBL14863300 0.70 MAPT (0.44) HIF1ACYP1A2MAPTHPGDHTT
SCHEMBL13748606 0.69 MAPT (0.43) HIF1AALOX12CYP1A2ALDH1A1PHLPP2
SCHEMBL27449497 0.68 ALDH1A1 (0.36) ALDH1A1MAPTHTTKDM4EALOX15
SCHEMBL5270890 0.68 HIF1A (0.44) HIF1AALOX12CYP1A2ALDH1A1PHLPP2
SCHEMBL5499753 0.67 IGF1R (0.36) ALOX12ALDH1A1HSD17B10MAPTHPGD
SCHEMBL23095650 0.67 AGER (0.55) HIF1AALOX12CYP1A2ALDH1A1PHLPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2391602-B1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2013-12-04 EP disclosed
US-8362065-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-01-29 US disclosed
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed
CN-102325753-A Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL MYERS SQUIBB CO 2012-01-18 CN disclosed
US-8084620-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2011-12-27 US disclosed
EP-2391602-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2011-12-07 EP disclosed
WO-2010080481-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-15 WO disclosed
US-20100160303-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 HIF1A 4130/4885ALOX12 4551/4885CYP1A2 2286/4885
US-20100160303-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 HIF1A 4130/4885ALOX12 4551/4885CYP1A2 2286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.